Literature DB >> 17503779

Biologic functions of the G12 subfamily of heterotrimeric g proteins: growth, migration, and metastasis.

Patrick Kelly1, Patrick J Casey, Thomas E Meigs.   

Abstract

The G12 subfamily of heterotrimeric G proteins has been the subject of intense scientific interest for more than 15 years. During this period, studies have revealed more than 20 potential G12-interacting proteins and numerous signaling axes emanating from the G12 proteins, Galpha12 and Galpha13. In addition, more recent studies have begun to illuminate the various and sundry functions that the G12 subfamily plays in biology. In this review, we summarize the diverse range of proteins that have been identified as Galpha12 and/or Galpha13 interactors and describe ongoing studies designed to dissect the biological roles of specific Galpha-effector protein interactions. Further, we describe and discuss the expanding role of G12 proteins in the biology of cells, focusing on the distinct properties of this subfamily in regulating cell proliferation, cell migration, and metastatic invasion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503779     DOI: 10.1021/bi700235f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  57 in total

1.  Regulation of integrin expression by Gα12: An additional potential mechanism modulating cell attachment.

Authors:  Tianqing Kong; Daosong Xu; Mei Tran; Bradley M Denker
Journal:  Cell Adh Migr       Date:  2010-07-01       Impact factor: 3.405

2.  The alpha subunit of the G protein G13 regulates activity of one or more Gli transcription factors independently of smoothened.

Authors:  Andrew E Douglas; Jennifer A Heim; Feng Shen; Luciana L Almada; Natalia A Riobo; Martin E Fernández-Zapico; David R Manning
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

3.  Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA.

Authors:  Jun Wang; Paula H Stern
Journal:  J Cell Biochem       Date:  2010-12-15       Impact factor: 4.429

Review 4.  Role of G12 proteins in oncogenesis and metastasis.

Authors:  Juhi Juneja; Patrick J Casey
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

Review 5.  Regulation and physiological functions of G12/13-mediated signaling pathways.

Authors:  Nobuchika Suzuki; Nicole Hajicek; Tohru Kozasa
Journal:  Neurosignals       Date:  2009-02-12

6.  Gα12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells.

Authors:  Kyu Min Kim; Chang Yeob Han; Ji Young Kim; Sam Seok Cho; Yun Seok Kim; Ja Hyun Koo; Jung Min Lee; Sung Chul Lim; Keon Wook Kang; Jae-Sung Kim; Se Jin Hwang; Sung Hwan Ki; Sang Geon Kim
Journal:  J Hepatol       Date:  2018-01-02       Impact factor: 25.083

7.  MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells.

Authors:  Suhail Ahmed Kabeer Rasheed; Cui Rong Teo; Emmanuel Jean Beillard; P Mathijs Voorhoeve; Patrick J Casey
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

8.  Gα12 structural determinants of Hsp90 interaction are necessary for serum response element-mediated transcriptional activation.

Authors:  Ellyn R Montgomery; Brenda R S Temple; Kimberly A Peters; Caitlin E Tolbert; Brandon K Booker; Joseph W Martin; Tyler P Hamilton; Alicia C Tagliatela; William C Smolski; Stephen L Rogers; Alan M Jones; Thomas E Meigs
Journal:  Mol Pharmacol       Date:  2014-01-16       Impact factor: 4.436

9.  The Gq and G12 families of heterotrimeric G proteins report functional selectivity.

Authors:  Li Zhang; Lawrence F Brass; David R Manning
Journal:  Mol Pharmacol       Date:  2008-10-24       Impact factor: 4.436

Review 10.  Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes.

Authors:  Vijay Yanamadala; Hideyuki Negoro; Bradley M Denker
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.